| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 12 5529-5534, Copyright © 1993 by American Association of Immunologists
ARTICLES |
SM Thomas, LF Garrity, CR Brandt, CS Schobert, GS Feng, MW Taylor, JM Carlin and GI Byrne
Department of Medical Microbiology, University of Wisconsin-Madison Medical School 53706.
The role of indoleamine 2,3-dioxygenase (IDO) in IFN-gamma-mediated inhibition of intracellular parasite growth has been examined previously, although earlier work has been largely correlative. In this study, we defined more completely the role of IDO in the IFN- antimicrobial response. Two mutant cell lines, derived from ME180 cells and exhibiting reduced IDO activity (IR3B6A, IR3B6B) were characterized to determine if they retained the capacity to inhibit intracellular Chlamydia and Toxoplasma growth. Mutant cells treated with IFN-gamma exhibited reduced capacity to suppress pathogen growth. The expression of several IFN-regulated genes also was measured to confirm that the inability to inhibit pathogen growth was because of the lack of IDO. The expression of class II MHC, intracellular adhesion molecule-1, MxA, and P68 kinase genes was induced in the IFN-gamma-treated wild type ME180 cells, but was variable in the mutant cell lines, supporting the hypothesis that IFN-gamma-induced production of IDO is a key IFN-gamma- mediated antimicrobial mechanism.
This article has been cited by other articles:
|
|
 |
|
  K. Mohib, S. Wang, Q. Guan, A. L. Mellor, H. Sun, C. Du, and A. M. Jevnikar Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury Am J Physiol Renal Physiol, July 1, 2008; 295(1): F226 - F234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Coers, I. Bernstein-Hanley, D. Grotsky, I. Parvanova, J. C. Howard, G. A. Taylor, W. F. Dietrich, and M. N. Starnbach Chlamydia muridarum Evades Growth Restriction by the IFN-{gamma}-Inducible Host Resistance Factor Irgb10 J. Immunol., May 1, 2008; 180(9): 6237 - 6245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Riesenberg, C. Weiler, O. Spring, M. Eder, A. Buchner, T. Popp, M. Castro, R. Kammerer, O. Takikawa, R. A. Hatz, et al. Expression of Indoleamine 2,3-Dioxygenase in Tumor Endothelial Cells Correlates with Long-term Survival of Patients with Renal Cell Carcinoma Clin. Cancer Res., December 1, 2007; 13(23): 6993 - 7002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mohib, Q. Guan, H. Diao, C. Du, and A. M. Jevnikar Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells Am J Physiol Renal Physiol, September 1, 2007; 293(3): F801 - F812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Seymour, V. Ganapathy, A. L. Mellor, and D. H. Munn A high-affinity, tryptophan-selective amino acid transport system in human macrophages J. Leukoc. Biol., December 1, 2006; 80(6): 1320 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Appelberg Macrophage nutriprive antimicrobial mechanisms J. Leukoc. Biol., June 1, 2006; 79(6): 1117 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Qiao, S. Prabhakar, A. Canova, Y. Hoshino, M. Weiden, and R. Pine Posttranscriptional Inhibition of Gene Expression by Mycobacterium tuberculosis Offsets Transcriptional Synergism with IFN-{gamma} and Posttranscriptional Up-Regulation by IFN-{gamma} J. Immunol., March 1, 2004; 172(5): 2935 - 2943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Mellor and D. H. Munn Tryptophan Catabolism and Regulation of Adaptive Immunity J. Immunol., June 15, 2003; 170(12): 5809 - 5813. [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Sakash, G. I. Byrne, A. Lichtman, and P. Libby Cytokines Induce Indoleamine 2,3-Dioxygenase Expression in Human Atheroma-Associated Cells: Implications for Persistent Chlamydophila pneumoniae Infection Infect. Immun., July 1, 2002; 70(7): 3959 - 3961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sedlmayr, A. Blaschitz, R. Wintersteiger, M. Semlitsch, A. Hammer, C.R. MacKenzie, W. Walcher, O. Reich, O. Takikawa, and G. Dohr Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta Mol. Hum. Reprod., April 1, 2002; 8(4): 385 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Silva, C. V. Rodrigues, M. M. Santoro, L. F. L. Reis, J. I. Alvarez-Leite, and R. T. Gazzinelli Expression of Indoleamine 2,3-Dioxygenase, Tryptophan Degradation, and Kynurenine Formation during In Vivo Infection with Toxoplasma gondii: Induction by Endogenous Gamma Interferon and Requirement of Interferon Regulatory Factor 1 Infect. Immun., February 1, 2002; 70(2): 859 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Alexander, M. Crawford, S. Bertera, W. A. Rudert, O. Takikawa, P. D. Robbins, and M. Trucco Indoleamine 2,3-Dioxygenase Expression in Transplanted NOD Islets Prolongs Graft Survival After Adoptive Transfer of Diabetogenic Splenocytes Diabetes, February 1, 2002; 51(2): 356 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Pantoja, R. D. Miller, J. A. Ramirez, R. E. Molestina, and J. T. Summersgill Characterization of Chlamydia pneumoniae Persistence in HEp-2 Cells Treated with Gamma Interferon Infect. Immun., December 1, 2001; 69(12): 7927 - 7932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Ramsey, G. S. Miranpuri, I. M. Sigar, S. Ouellette, and G. I. Byrne Chlamydia trachomatis Persistence in the Female Mouse Genital Tract: Inducible Nitric Oxide Synthase and Infection Outcome Infect. Immun., August 1, 2001; 69(8): 5131 - 5137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Rottenberg, A. Gigliotti Rothfuchs, D. Gigliotti, M. Ceausu, C. Une, V. Levitsky, and H. Wigzell Regulation and Role of IFN-{gamma} in the Innate Resistance to Infection with Chlamydia pneumoniae J. Immunol., May 1, 2000; 164(9): 4812 - 4818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Pais and R. Appelberg Macrophage Control of Mycobacterial Growth Induced by Picolinic Acid Is Dependent on Host Cell Apoptosis J. Immunol., January 1, 2000; 164(1): 389 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. P. Ceravolo, A. C. L. Chaves, C. A. Bonjardim, D. Sibley, A. J. Romanha, and R. T. Gazzinelli Replication of Toxoplasma gondii, but Not Trypanosoma cruzi, Is Regulated in Human Fibroblasts Activated with Gamma Interferon: Requirement of a Functional JAK/STAT Pathway Infect. Immun., May 1, 1999; 67(5): 2233 - 2240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Kane, R. M. Vena, S. P. Ouellette, and G. I. Byrne Intracellular Tryptophan Pool Sizes May Account for Differences in Gamma Interferon-Mediated Inhibition and Persistence of Chlamydial Growth in Polarized and Nonpolarized Cells Infect. Immun., April 1, 1999; 67(4): 1666 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Rottenberg, A. C. Gigliotti Rothfuchs, D. Gigliotti, C. Svanholm, L. Bandholtz, and H. Wigzell Role of Innate and Adaptive Immunity in the Outcome of Primary Infection with Chlamydia pneumoniae, as Analyzed in Genetically Modified Mice J. Immunol., March 1, 1999; 162(5): 2829 - 2836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Kane and G. I. Byrne Differential Effects of Gamma Interferon on Chlamydia trachomatis Growth in Polarized and Nonpolarized Human Epithelial Cells in Culture Infect. Immun., May 1, 1998; 66(5): 2349 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Ramsey, G. S. Miranpuri, C. E. Poulsen, N. B. Marthakis, L. M. Braune, and G. I. Byrne Inducible Nitric Oxide Synthase Does Not Affect Resolution of Murine Chlamydial Genital Tract Infections or Eradication of Chlamydiae in Primary Murine Cell Culture Infect. Immun., February 1, 1998; 66(2): 835 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 KouacouV. Konan and MiltonW. Taylor Importance of the Two Interferon-stimulated Response Element (ISRE) Sequences in the Regulation of the Human Indoleamine 2,3-Dioxygenase Gene J. Biol. Chem., August 9, 1996; 271(32): 19140 - 19145. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
